Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.918

-13.4%

Dec 15 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hope who wrote (9675)	7/8/1998 3:33:00 PM
From: UncleWaltie	Read Replies (2) of 14328

Looks like good news bad news to me. Good news that acquisition of product line will be help earnings without further stock dilution. But doesn't extending warrants with reduced exercise price mean added risk of further stock dilution and that in someone's view that the stock is less likely to reach $4. Seems the only people to benefit are B warrant holders. Who is the management helping by doing this? Please correct me if I'm wrong. I was planning to add to my position at these low prices until I saw the warrant news. Fear of continued dilution and all that. Thanks, uw

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next